From left to right: Mr Bjorn Bartolo (Technoline Ltd.); Prof. Kevin Cassar (Competition judge, Consultant vascular surgeon, Clinical lead Vascular Surgery, Mater Dei Hospital); Mr Keith Sammut (BioSA researcher from Mater Dei Hospital); Mr Thomas Azzopardi (Consultant Orthopaedic surgeon, Orthopaedic postgraduate training coordinator, Mater Dei Hospital); and Prof. Stephen Fava (Competition judge, consultant Physician and Chairman of the Department of Medicine, Mater Dei Hospital).
A group of researchers in a joint collaboration between the University of Malta and Mater Dei Hospital, is behind the development of a novel biodegradable metallic bone scaffold intended to treat patients with bone defects. A patent of this invention has been filed. This research is part of the MCST-funded BioSA project (Biodegradable Iron for Orthopaedic Scaffold Applications).
Mr Keith Sammut won first prize out of 16 papers for his work on In-vitro anti-biofilm properties of novel biodegradable silver-enhanced iron-manganese bone scaffolds. Mr Keith Sammut is a Higher Specialist Trainee in Orthopaedic Surgery at Mater Dei Hospital, and is reading for a Master of Science in Molecular and Cell Biology (by Part-Time Research) degree and is supervised by Prof. Pierre Schembri Wismayer, Prof. Ing. Joseph Buhagiar and Prof. Vasilis Valdramidis. Technological support is being provided by Dr Foteini Pavli and Ms Christabelle Tonna. Mr Ryan Giordmaina and Mr Ray Gatt of the Department of Orthopaedics, Trauma & Sports Medicine of Mater Dei Hospital are part of the BioSA team and are providing application support.
BioSA is financed by the Malta Council for Science and Technology, for and on behalf of the Foundation for Science and Technology, through the FUSION: R&I Technology Development Programme. (BioSA R&I-2017-037T).